All stories
AlphaFold: How AI Solved Biology's 50-Year Problem (2020)  -  Moments | AI History by CobuildX
CobuildX
2020Moments

AlphaFold: How AI Solved Biology's 50-Year Problem

AlphaFold solved protein folding, a 50-year-old grand challenge of biology, in a weekend of competition.

AlphaFoldDeepMindprotein foldingstructural biologyNobel Prize Chemistry 2024drug discovery AI

Proteins are the machines of biology. Chains of amino acids fold into precise three-dimensional shapes, and those shapes determine what the proteins do, whether they catalyse a reaction, form a membrane, carry oxygen, or signal between cells. For 50 years, determining a protein's structure from its amino acid sequence was one of biology's hardest open problems. X-ray crystallography and cryo-electron microscopy could measure structures, but were slow, expensive, and often impossible for certain proteins. The gap between known sequences and known structures was growing.

The CASP competition (Critical Assessment of protein Structure Prediction) had run biannually since 1994, benchmarking computational methods for predicting protein structure. DeepMind entered CASP13 in 2018 with AlphaFold 1 and placed first. At CASP14 in November 2020, AlphaFold 2 achieved something that stunned the structural biology community: it predicted protein structures with accuracy comparable to experimental methods, a Global Distance Test score of over 90, where previous best methods scored around 70.

AlphaFold 2's architecture combined multiple sequence alignments (to find evolutionarily related proteins), a novel "Evoformer" transformer block that jointly processed sequence and pairwise residue relationships, and a structure module that used the learned representations to predict atomic coordinates. The training signal was experimental structures from the Protein Data Bank. It was, at its core, a transformer applied to biology with exceptional care for the domain's geometry.

In 2021, DeepMind released AlphaFold 2's code and weights openly, and partnered with the European Bioinformatics Institute to release predicted structures for 200 million proteins, essentially every known protein in every organism sequenced. The database has been used to accelerate drug discovery, understand disease mechanisms, and design new enzymes. John Jumper and Demis Hassabis received the 2024 Nobel Prize in Chemistry for AlphaFold. The problem that had stumped structural biology for 50 years was solved by a team that had been working on games four years earlier.

What it actually meant

AlphaFold worked because DeepMind had access to decades of experimental structural biology data and designed an architecture that exploited what that data encoded. The scientific breakthrough required the scientific database. AI capability is bounded by the quality and coverage of the domain data that grounds it.

What enterprises get wrong today

Enterprises with proprietary data assume the data alone is the competitive moat. It is necessary but not sufficient. Proprietary data only becomes an advantage when paired with the right task formulation, the right architecture, and the infrastructure to train, evaluate, and deploy. Raw data hoarded and unused is a cost centre, not an asset.

Related capabilities

AI History

Ask about this story

Explore this history

AlphaFold solved the 50-year protein folding problem so decisively that it won the Nobel Prize in Chemistry. A team that had been playing Atari games four years earlier. What would you like to explorethe biology, the architecture, or what it means for drug discovery?